| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.71▼ | 2.68▼ | 2.68▼ | 2.70▼ | 3.31▼ |
| MA10 | 2.73▼ | 2.77▼ | 2.77▼ | 2.88▼ | 3.64▼ |
| MA20 | 2.87▼ | 3.00▼ | 3.05▼ | 3.38▼ | N/A |
| MA50 | 3.22▼ | 3.44▼ | 3.54▼ | 3.69▼ | N/A |
| MA100 | 3.58▼ | 3.81▼ | 3.79▼ | N/A | N/A |
| MA200 | 3.71▼ | 3.93▼ | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.013▼ | -0.024▼ | -0.094▼ | N/A |
| RSI | 31.842▼ | 34.232▼ | 34.268▼ | 34.561▼ | 40.866▼ |
| STOCH | 33.036 | 28.325 | 15.875▼ | 9.614▼ | N/A |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -100.000▼ | -100.000▼ |
| CCI | -189.489▼ | -164.950▼ | -145.191▼ | -98.417 | -209.538▼ |
|
Thursday, August 14, 2025 01:27 PM
Clinical trial advances for INSTASYL siRNA lead product candidate PH-7625th cohort enrolling patients in on-going clinical studyKing of Prussia, Pennsylvania--(Newsfile Corp. - August 14, 2025) - Phio ...
|
|
Tuesday, August 12, 2025 02:15 PM
PM Eastern Time, today. LOS ANGELES, CALIFORNIA / ACCESS Newswire / August 12, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered ...
|
|
Thursday, August 07, 2025 01:15 PM
Data from Phase 1 clinical trial of ATH-1105 in healthy volunteers showed a favorable safety and tolerability profile; dose proportional pharmacokinetics and CNS penetration support continued clinical ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 2.70 | 2.70 | 2.51 | 2.51 | 4,422 |
| 14/08/25 | 2.71 | 2.80 | 2.60 | 2.60 | 4,464 |
| 13/08/25 | 2.80 | 2.90 | 2.61 | 2.655 | 13,579 |
| 12/08/25 | 2.85 | 3.05 | 2.61 | 2.72 | 3,668 |
| 11/08/25 | 2.77 | 3.00 | 2.77 | 3.00 | 10,045 |
| 08/08/25 | 2.86 | 3.04 | 2.55 | 2.71 | 26,907 |
| 07/08/25 | 3.18 | 3.20 | 2.80 | 2.80 | 3,500 |
| 06/08/25 | 2.955 | 3.1762 | 2.955 | 3.16 | 7,192 |
| 05/08/25 | 3.50 | 3.79 | 2.90 | 3.10 | 331,557 |
| 04/08/25 | 3.719 | 4.15 | 3.55 | 3.5601 | 151,376 |
|
|
||||
|
|
||||
|
|